The FDA has approved lenacapavir, a groundbreaking antiviral drug for HIV prevention developed by biochemist Wesley Sundquist. Learn how this drug could change the future of HIV treatment and prevention.
Today, the U.S. Supreme Court hears a pivotal case on Obamacare's preventive care mandate, with major implications for health coverage, including HIV prevention drugs like PrEP. Conservative employers argue the mandate is unconstitutional, raising fears about the future of essential health services.
